Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants

Early surgical treatment is recommended to reduce morbidity and mortality in patients with fragility hip fractures. Anticoagulation treatment poses a surgical challenge. While the action of vitamin K antagonists (VKAs) can be reversed, for direct oral anticoagulants (DOACs) antidote is only availabl...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2018-06, Vol.166, p.106-112
Hauptverfasser:	Frenkel Rutenberg, Tal, Velkes, Steven, Vitenberg, Maria, Leader, Avi, Halavy, Yael, Raanani, Pia, Yassin, Mustafa, Spectre, Galia
Format:	Artikel
Sprache:	eng
Schlagworte:	DOACs-direct oral anticoagulants Fragility fractures Morbidity Mortality NOACs-novel anticoagulants Vitamin K antagonists
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!